BioSpace News Archive

DarioHealth Corp. reported financial results for the fourth quarter and full year ended December 31, 2019 and provided a corporate and commercial update.

Gefapixant Demonstrated Statistically Significant Decrease in 24-hour Coughs Per Hour Compared to Placebo at Week 12 and 24 in Phase 3 Trials

Parallax Health Sciences, Inc. announced that in collaboration with Harvard In Tech, Harvard University’s official Alumni Group for Technology, there will be a jointly hosted live webinar, entitled “c-19 Testing, Telehealth, Technology and Data Driven Solutions” to be broadcast at 1:00 PM EDT on Wednesday, March 18th from Parallax’s Good Health Outcomes website and will be available at www.goodhealthoutcomes.com also free to the public.

WellCare Medicare Advantage members in South Carolina now have in-network access to AnMed Health’s five-hospital system and healthcare providers.

Regeneron has identified hundreds of virus-neutralizing antibodies; plans to initiate large-scale manufacturing by mid-April with antibody cocktail therapy

Conference call to discuss the data and strategy for the program originally scheduled for 8 a.m. ET on March 18, 2020 has been postponed

Company developing COVID-19 assessment capabilities through Sydney Care mobile app

Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announced today further details on the Material Transfer Agreement (MTA) signed with a leading public health-focused U.S. university and top coronavirus expert. Under the terms of the confidential agreement, virologists plan to evaluate the potential antiviral properties of Brilacidin, the Company’s lead defensin-mimetic drug candidate, t

Independent research suggests new approach to inhibiting the viral replication capability of a range of viruses, including Coronavirus

Nobio Ltd. and Supergum (1983) Ltd. today announced an agreement to rapidly prototype and test an antiviral protective mask, combining Nobio’s revolutionary antimicrobial technology and Supergum’s market leading CBRN (chemical, biological, radiological and nuclear) breathing protection products. Nobio’s